Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: This case is about infringement not validity....Right?

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

This case is about infringement not validity....Right?

l2007s

Dec 04, 2007 06:35AM

Re: This case is about infringement not validity....Right?

CenturyCom

Dec 04, 2007 06:42AM

Re: This case is about infringement not validity....Right?

jrumpqua

Dec 04, 2007 06:44AM

Re: This case is about infringement not validity....Right? jrumpqua

SGE1

Dec 04, 2007 07:09AM

sdlittle

Rank: President [?]

Points: 1633 [?]

Votes: 31 Score: 2.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: This case is about infringement not validity....Right?

in response to

This case is about infringement not validity....Right?

l2007s

posted on Dec 04, 2007 07:18AM

Actually, I believe part of the J's defense does deal with the validity of the patents. The applicability of ACP has been a big topic primarily because the validity part of the J's defense would be weakened considerably if Judge Ward decides not to go against the CA ruling against B&O/PTSC. I personally believe that one of the primary reasons for the 30-day stay had to do with Judge Ward's inclination related the ACP issue.